Benign Prostatic Hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with PSA levels below 4ng/ml, or those whose imaging data do not suggest suspicious cancer nodules or the possibility of prostate cancer; 2. Patients with prostate volume greater than 80ml as indicated by preoperative ultrasound or MRI; 3. Patients with a life expectancy greater than 10 years; 4. Patients who can tolerate general anesthesia as assessed by anesthesiologists.
Exclusion criteria
Exclusion criteria: 1. Patients with a life expectancy less than 10 years or who cannot tolerate surgical treatment. 2. Patients who cannot complete prostate-related imaging examinations. 3. Patients who have high requirements for functional preservation, such as sexual function and urinary control, and cannot accept surgical complications. 4. Patients with urodynamic examination results or other evidence suggesting possible neurogenic bladder. 5. Patients with prostate malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operation time;Operative blood loss;Prostate Tissue Clearance Rate;Duration of hospitalization; | — |
Secondary
| Measure | Time frame |
|---|---|
| Maximum urinary flow rate (Qmax);Residual Urine in Bladder;IPSS(QoL);IIEF-5 Form;Urinary Incontinence (Pad Test); | — |
Countries
China
Contacts
The Second Affiliated Hospital of Soochow University